Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi-center study [documento electrónico] / Carlos Esteban Builes Montaño, ; Carolina Prieto Saldarriaga, ; Clara María Arango Toro,  . - 2021.
Obra : Journal of Clinical Apheresis

Idioma : Inglés (eng)

Palabras clave :	anti-thyroid agents  hyperthyroidism  Latin America  plasmapheresis  thyrotoxicosis
Resumen :	Background and aims: Thyroid storm and severe thyrotoxicosis remain among the most frequent endocrine emergencies, and first-line hyperthyroidism treatment is not always an option. Since the first report in 1970, plasmapheresis is a second-line treatment for severe or otherwise untreatable thyrotoxicosis when rapid euthyroidism is desired. Methods: We present a retrospective study of the experience in treating thyrotoxicosis with plasmapheresis between 2012 and 2020 in two specialized centers in Colombia. We register the demographic and clinical characteristic and compare the thyroid hormones and other biochemical measurements before and after treatment. Results: Data from 19 patients was obtained, 58% female with a median age of 35 years (IQR 23.5), and most of them with Graves' disease. The most frequent indication for plasmapheresis was thyroid storm. A median of 4 (IQR 2) sessions lead to a significant reduction in FT4 (P .0001) and TT3 (P
Mención de responsabilidad :	Carlos E. Builes-Montaño,Luis A. Rodriguez-Arrieta,Alejandro Román-González,Carolina Prieto-Saldarriaga,Jose C. Alvarez-Payares,Carlos A. Builes-Barrera,Clara M. Arango-Toro
Referencia :	J Clin Apher. 2021 Oct;36(5):759-765.
DOI (Digital Object Identifier) :	10.1002/jca.21927
PMID :	34273178
En línea :	https://onlinelibrary.wiley.com/doi/10.1002/jca.21927
Enlace permanente :	https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5818